SCHEMBL19984729

SCHEMBL19984729

CC(C)(C)OC(=O)NCc1cnc(C2CCC(=O)C2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.36
FPR3 P25089 2/20 0.36
FPR2 P25090 2/20 0.36
PDPK1 O15530 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
STK17B O94768 1/20 0.34
STK17A Q9UEE5 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
IGF1R P08069 1/20 0.34
MALT1 Q9UDY8 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
SIRT3 Q9NTG7 1/20 0.33
CKS1B P61024 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18667146 0.85 ALDH1A1 (0.37) GFERFPR3FPR2PDPK1L3MBTL1
SCHEMBL18667622 0.75 L3MBTL1 (0.42) GFERPDPK1L3MBTL1CA12CA1
SCHEMBL18667145 0.74 L3MBTL1 (0.42) GFERFPR3FPR2L3MBTL1CA12
SCHEMBL18209793 0.74 L3MBTL1 (0.41) FPR3FPR2PDPK1L3MBTL1CA12
SCHEMBL18381560 0.74 SMN1; SMN2 (0.48) PDPK1L3MBTL1CA12CA1CA2
SCHEMBL18666971 0.74 STK17B (0.44) L3MBTL1STK17BSTK17AMAPKAPK2
SCHEMBL19975191 0.73 L3MBTL1 (0.33) L3MBTL1
SCHEMBL1903376 0.72 SMN1; SMN2 (0.45) FPR3FPR2L3MBTL1CA1CA2
SCHEMBL18667614 0.72 LMNA (0.42) FPR3FPR2PDPK1L3MBTL1CA12
SCHEMBL19984728 0.72 DYRK1A (0.37) GFERFPR3FPR2PDPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS GFER 2833/4885FPR3 4031/4885FPR2 3135/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS GFER 2833/4885FPR3 4031/4885FPR2 3135/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS GFER 2833/4885FPR3 4031/4885FPR2 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.